Brief: Cardiex Says Entered Into New Global Clinical Trial Services Agreement With Andwin Scientific
14/02/2022 01:31
Feb 14 (Reuters) - Cardiex Ltd CDX.AX :
* UNIT ENTERED INTO A NEW GLOBAL CLINICAL TRIAL SERVICES
AGREEMENT
WITH ANDWIN SCIENTIFIC
* SERVICES AGREEMENT FOR PROVISION OF ATCOR XCEL DEVICES AND
DATA
MANAGEMENT SERVICES
Source text for Eikon: ID:nASX89wXX8
Further company coverage: CDX.AX
Recent news on Conneqt Health
See all newsAustralia's CONNEQT Health set for biggest weekly gain in 11 months on US distribution deal
Australia's CONNEQT Health extends gains on deal with US-based Blueprint
Australia's Conneqt Health gains most in over 5-months on U.S. distribution deal
Brief: Conneqt Health Enters Commercial Marketing Agreement With Blueprint
Brief: Conneqt Health Posts FY Net Loss Of A$10.86 Million